These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 33231861)

  • 1. Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review.
    Murton M; Goff-Leggett D; Bobrowska A; Garcia Sanchez JJ; James G; Wittbrodt E; Nolan S; Sörstadius E; Pecoits-Filho R; Tuttle K
    Adv Ther; 2021 Jan; 38(1):180-200. PubMed ID: 33231861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
    Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
    J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and determinants of chronic kidney disease in the Swiss population.
    Forni Ogna V; Ogna A; Ponte B; Gabutti L; Binet I; Conen D; Erne P; Gallino A; Guessous I; Hayoz D; Muggli F; Paccaud F; Péchère-Bertschi A; Suter PM; Bochud M; Burnier M
    Swiss Med Wkly; 2016; 146():w14313. PubMed ID: 27152492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
    Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC
    Am J Kidney Dis; 2021 Jan; 77(1):23-34.e1. PubMed ID: 32971190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Pugliese G; Solini A; Bonora E; Orsi E; Zerbini G; Fondelli C; Gruden G; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Penno G;
    Cardiovasc Diabetol; 2014 Mar; 13():59. PubMed ID: 24624891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging.
    Bailey RA; Wang Y; Zhu V; Rupnow MF
    BMC Res Notes; 2014 Jul; 7():415. PubMed ID: 24990184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria : The Screening for CKD among Older People across Europe (SCOPE) study.
    Moreno-Gonzalez R; Corbella X; Mattace-Raso F; Tap L; Sieber C; Freiberger E; Kostka T; Guligowska A; Melzer I; Melzer Y; Carlsson AC; Ärnlöv J; Roller-Wirnsberger R; Wirnsberger G; Gil P; Martinez SL; Fabbietti P; Corsonello A; Lattanzio F; Formiga F;
    BMC Geriatr; 2020 Oct; 20(Suppl 1):327. PubMed ID: 33008317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of chronic kidney disease after preeclampsia.
    Lopes van Balen VA; Spaan JJ; Cornelis T; Spaanderman MEA
    J Nephrol; 2017 Jun; 30(3):403-409. PubMed ID: 27491315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study.
    Kaze FF; Halle MP; Mopa HT; Ashuntantang G; Fouda H; Ngogang J; Kengne AP
    BMC Nephrol; 2015 Jul; 16():96. PubMed ID: 26149764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, clinical, and laboratory factors associated with chronic kidney disease in Mexican HIV-infected patients.
    Lopez ED; Córdova-Cázarez C; Valdez-Ortiz R; Cardona-Landeros CM; Gutiérrez-Rico MF
    J Bras Nefrol; 2019; 41(1):48-54. PubMed ID: 30010693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis.
    Ponte B; Pruijm M; Marques-Vidal P; Martin PY; Burnier M; Paccaud F; Waeber G; Vollenweider P; Bochud M
    Nephrol Dial Transplant; 2013 Sep; 28(9):2329-39. PubMed ID: 23825103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease].
    Shakhmatova OO; Komarov AL; Krivosheeva EN; Dobrovolsky AB; Titaeva EV; Amelyushkina VA; Gomyranova NV; Panchenko EP
    Ter Arkh; 2023 Nov; 95(9):763-768. PubMed ID: 38158919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of human immunodeficiency virus-infected patients with chronic kidney disease using a combination of proteinuria and estimated glomerular filtration rate.
    Yanagisawa N; Muramatsu T; Yamamoto Y; Tsuchiya K; Nitta K; Ajisawa A; Fukutake K; Ando M
    Clin Exp Nephrol; 2014 Aug; 18(4):600-5. PubMed ID: 23955325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening.
    Otieno FCF; Ogola EN; Kimando MW; Mutai K
    BMC Nephrol; 2020 Feb; 21(1):73. PubMed ID: 32111192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.